Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 9.76
+0.18 (1.91%)
At close: Apr 29, 2026
SHE:301301 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2019 |
| Market Capitalization | 21,766 | 22,613 | 26,414 | 18,672 | 19,894 | - | Upgrade
|
| Market Cap Growth | -22.74% | -14.39% | 41.47% | -6.14% | - | - | Upgrade
|
| Enterprise Value | 22,345 | 23,118 | 27,694 | 19,880 | 23,096 | - | Upgrade
|
| Last Close Price | 9.76 | 10.14 | 11.61 | 8.10 | 8.55 | - | Upgrade
|
| PE Ratio | 37.31 | 29.41 | 18.86 | 19.85 | 48.34 | - | Upgrade
|
| Forward PE | 21.22 | 22.87 | 16.86 | 20.74 | - | - | Upgrade
|
| PS Ratio | 4.93 | 4.90 | 4.59 | 3.87 | 5.21 | - | Upgrade
|
| PB Ratio | 2.65 | 2.79 | 3.34 | 2.68 | 3.20 | - | Upgrade
|
| P/TBV Ratio | 2.74 | 2.88 | 3.45 | 2.79 | 3.36 | - | Upgrade
|
| P/FCF Ratio | 42.58 | 50.05 | 15.11 | 19.71 | 30.87 | - | Upgrade
|
| P/OCF Ratio | 35.38 | 41.19 | 14.75 | 14.45 | 28.76 | - | Upgrade
|
| PEG Ratio | - | 0.56 | 0.56 | - | - | - | Upgrade
|
| EV/Sales Ratio | 5.06 | 5.01 | 4.81 | 4.12 | 6.05 | - | Upgrade
|
| EV/EBITDA Ratio | 16.43 | 15.00 | 12.16 | 11.49 | 18.98 | - | Upgrade
|
| EV/EBIT Ratio | 29.20 | 23.79 | 15.95 | 16.76 | 34.43 | - | Upgrade
|
| EV/FCF Ratio | 43.72 | 51.16 | 15.84 | 20.99 | 35.84 | - | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.15 | 0.18 | 0.28 | 0.53 | 0.77 | Upgrade
|
| Debt / EBITDA Ratio | 0.90 | 0.76 | 0.62 | 1.12 | 2.68 | 3.99 | Upgrade
|
| Debt / FCF Ratio | 2.38 | 2.63 | 0.82 | 2.05 | 5.07 | 4.89 | Upgrade
|
| Net Debt / Equity Ratio | 0.07 | 0.06 | 0.04 | 0.17 | 0.26 | 0.66 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.41 | 0.29 | 0.15 | 0.68 | 1.34 | 3.44 | Upgrade
|
| Net Debt / FCF Ratio | 1.09 | 1.00 | 0.19 | 1.24 | 2.53 | 4.21 | Upgrade
|
| Asset Turnover | 0.42 | 0.44 | 0.56 | 0.47 | 0.39 | 0.33 | Upgrade
|
| Inventory Turnover | 2.66 | 2.32 | 2.44 | 2.19 | 2.04 | 1.82 | Upgrade
|
| Quick Ratio | 1.64 | 1.44 | 1.37 | 0.85 | 1.13 | 0.66 | Upgrade
|
| Current Ratio | 2.57 | 2.41 | 2.13 | 1.56 | 1.67 | 1.25 | Upgrade
|
| Return on Equity (ROE) | 7.19% | 9.59% | 18.81% | 14.27% | 7.49% | 2.36% | Upgrade
|
| Return on Assets (ROA) | 4.53% | 5.79% | 10.49% | 7.22% | 4.22% | 2.56% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.16% | 9.46% | 17.70% | 12.48% | 7.17% | 4.03% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.70% | 11.20% | 20.20% | 15.60% | 8.70% | 5.80% | Upgrade
|
| Earnings Yield | 2.72% | 3.40% | 5.30% | 5.04% | 2.07% | - | Upgrade
|
| FCF Yield | 2.35% | 2.00% | 6.62% | 5.07% | 3.24% | - | Upgrade
|
| Dividend Yield | 1.77% | 1.71% | 2.33% | 2.78% | 1.09% | - | Upgrade
|
| Payout Ratio | 105.09% | 80.90% | 38.92% | 30.85% | 34.71% | 150.70% | Upgrade
|
| Buyback Yield / Dilution | -1.58% | -1.76% | 0.75% | -14.28% | -5.59% | 7.21% | Upgrade
|
| Total Shareholder Return | 0.18% | -0.05% | 3.07% | -11.50% | -4.51% | 7.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.